Search
Armata Pharmaceuticals Inc
ARMPAdd to Watchlist
3.620USD
-0.020-0.55%
Close 09-23 16:00（ET）
132.89MMarket Cap
LossP/E TTM
After-hours 16:10 (ET)3.620USD+0.020+0.56%
After-hours 16:10 (ET)Armata Pharmaceuticals Inc (ARMP) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Armata Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.500USD+380.77%
ARMP Analyst Recommendation Trends
In the current month, ARMP has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ARMP average Analyst price target in the last month is 17.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
1
1
ARMP Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, ARMP EPS is projected to reach -0.555 in FY2026Q3, following reported EPS of 2.018 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.28
-0.38
-0.45
-0.56
-0.40
Actual
-3.42
-3.16
2.02
--
--
Surprise
-1121.17%
-730.93%
+553.38%
--
--
FAQs
What is Armata Pharmaceuticals Inc's expected revenue for the next quarter?
Armata Pharmaceuticals Inc's expected revenue is 450.00K.
What is Armata Pharmaceuticals Inc's price target?
Analysts forecast that Armata Pharmaceuticals Inc's price target is USD 17.50, with the highest forecast at USD 20.00 and the lowest forecast at USD 15.00.
How have Armata Pharmaceuticals IncARMP's recent earnings per share performed?
The market expectation was USD 2.02, while Armata Pharmaceuticals IncARMP's earnings per share (EPS) for the previous quarter was USD -3.16. EPS for the next quarter is expected at USD -0.56.
What is the analyst rating for Armata Pharmaceuticals Inc?
Based on the ratings of Armata Pharmaceuticals Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.